Barriers to Infection of Human Cells by Feline Leukemia Virus: Insights into Resistance to Zoonosis
The human genome displays a rich fossil record of past gammaretrovirus infections, yet no current epidemic is evident, despite environmental exposure to viruses that infect human cells in vitro . Feline leukemia viruses (FeLVs) rank high on this list, but neither domestic nor workplace exposure has...
Saved in:
Published in | Journal of virology Vol. 91; no. 5 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.03.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0022-538X 1098-5514 1070-6321 1098-5514 |
DOI | 10.1128/JVI.02119-16 |
Cover
Abstract | The human genome displays a rich fossil record of past gammaretrovirus infections, yet no current epidemic is evident, despite environmental exposure to viruses that infect human cells
in vitro
. Feline leukemia viruses (FeLVs) rank high on this list, but neither domestic nor workplace exposure has been associated with detectable serological responses. Nonspecific inactivation of gammaretroviruses by serum factors appears insufficient to explain these observations. To investigate further, we explored the susceptibilities of primary and established human cell lines to FeLV-B, the most likely zoonotic variant. Fully permissive infection was common in cancer-derived cell lines but was also a feature of nontransformed keratinocytes and lung fibroblasts. Cells of hematopoietic origin were generally less permissive and formed discrete groups on the basis of high or low intracellular protein expression and virion release. Potent repression was observed in primary human blood mononuclear cells and a subset of leukemia cell lines. However, the early steps of reverse transcription and integration appear to be unimpaired in nonpermissive cells. FeLV-B was subject to G→A hypermutation with a predominant APOBEC3G signature in partially permissive cells but was not mutated in permissive cells or in nonpermissive cells that block secondary viral spread. Distinct cellular barriers that protect primary human blood cells are likely to be important in protection against zoonotic infection with FeLV.
IMPORTANCE
Domestic exposure to gammaretroviruses such as feline leukemia viruses (FeLVs) occurs worldwide, but the basis of human resistance to infection remains incompletely understood. The potential threat is evident from the human genome sequence, which reveals many past epidemics of gammaretrovirus infection, and from recent cross-species jumps of gammaretroviruses from rodents to primates and marsupials. This study examined resistance to infection at the cellular level with the most prevalent human cell-tropic FeLV variant, FeLV-B. We found that blood cells are uniquely resistant to infection with FeLV-B due to the activity of cellular enzymes that mutate the viral genome. A second block, which appears to suppress viral gene expression after the viral genome has integrated into the host cell genome, was identified. Since cells derived from other normal human cell types are fully supportive of FeLV replication, innate resistance of blood cells could be critical in protecting against cross-species infection. |
---|---|
AbstractList | The human genome displays a rich fossil record of past gammaretrovirus infections, yet no current epidemic is evident, despite environmental exposure to viruses that infect human cells in vitro. Feline leukemia viruses (FeLVs) rank high on this list, but neither domestic nor workplace exposure has been associated with detectable serological responses. Nonspecific inactivation of gammaretroviruses by serum factors appears insufficient to explain these observations. To investigate further, we explored the susceptibilities of primary and established human cell lines to FeLV-B, the most likely zoonotic variant. Fully permissive infection was common in cancer-derived cell lines but was also a feature of nontransformed keratinocytes and lung fibroblasts. Cells of hematopoietic origin were generally less permissive and formed discrete groups on the basis of high or low intracellular protein expression and virion release. Potent repression was observed in primary human blood mononuclear cells and a subset of leukemia cell lines. However, the early steps of reverse transcription and integration appear to be unimpaired in nonpermissive cells. FeLV-B was subject to G→A hypermutation with a predominant APOBEC3G signature in partially permissive cells but was not mutated in permissive cells or in nonpermissive cells that block secondary viral spread. Distinct cellular barriers that protect primary human blood cells are likely to be important in protection against zoonotic infection with FeLV. IMPORTANCE Domestic exposure to gammaretroviruses such as feline leukemia viruses (FeLVs) occurs worldwide, but the basis of human resistance to infection remains incompletely understood. The potential threat is evident from the human genome sequence, which reveals many past epidemics of gammaretrovirus infection, and from recent cross-species jumps of gammaretroviruses from rodents to primates and marsupials. This study examined resistance to infection at the cellular level with the most prevalent human cell-tropic FeLV variant, FeLV-B. We found that blood cells are uniquely resistant to infection with FeLV-B due to the activity of cellular enzymes that mutate the viral genome. A second block, which appears to suppress viral gene expression after the viral genome has integrated into the host cell genome, was identified. Since cells derived from other normal human cell types are fully supportive of FeLV replication, innate resistance of blood cells could be critical in protecting against cross-species infection. The human genome displays a rich fossil record of past gammaretrovirus infections, yet no current epidemic is evident, despite environmental exposure to viruses that infect human cells in vitro Feline leukemia viruses (FeLVs) rank high on this list, but neither domestic nor workplace exposure has been associated with detectable serological responses. Nonspecific inactivation of gammaretroviruses by serum factors appears insufficient to explain these observations. To investigate further, we explored the susceptibilities of primary and established human cell lines to FeLV-B, the most likely zoonotic variant. Fully permissive infection was common in cancer-derived cell lines but was also a feature of nontransformed keratinocytes and lung fibroblasts. Cells of hematopoietic origin were generally less permissive and formed discrete groups on the basis of high or low intracellular protein expression and virion release. Potent repression was observed in primary human blood mononuclear cells and a subset of leukemia cell lines. However, the early steps of reverse transcription and integration appear to be unimpaired in nonpermissive cells. FeLV-B was subject to G→A hypermutation with a predominant APOBEC3G signature in partially permissive cells but was not mutated in permissive cells or in nonpermissive cells that block secondary viral spread. Distinct cellular barriers that protect primary human blood cells are likely to be important in protection against zoonotic infection with FeLV.IMPORTANCE Domestic exposure to gammaretroviruses such as feline leukemia viruses (FeLVs) occurs worldwide, but the basis of human resistance to infection remains incompletely understood. The potential threat is evident from the human genome sequence, which reveals many past epidemics of gammaretrovirus infection, and from recent cross-species jumps of gammaretroviruses from rodents to primates and marsupials. This study examined resistance to infection at the cellular level with the most prevalent human cell-tropic FeLV variant, FeLV-B. We found that blood cells are uniquely resistant to infection with FeLV-B due to the activity of cellular enzymes that mutate the viral genome. A second block, which appears to suppress viral gene expression after the viral genome has integrated into the host cell genome, was identified. Since cells derived from other normal human cell types are fully supportive of FeLV replication, innate resistance of blood cells could be critical in protecting against cross-species infection.The human genome displays a rich fossil record of past gammaretrovirus infections, yet no current epidemic is evident, despite environmental exposure to viruses that infect human cells in vitro Feline leukemia viruses (FeLVs) rank high on this list, but neither domestic nor workplace exposure has been associated with detectable serological responses. Nonspecific inactivation of gammaretroviruses by serum factors appears insufficient to explain these observations. To investigate further, we explored the susceptibilities of primary and established human cell lines to FeLV-B, the most likely zoonotic variant. Fully permissive infection was common in cancer-derived cell lines but was also a feature of nontransformed keratinocytes and lung fibroblasts. Cells of hematopoietic origin were generally less permissive and formed discrete groups on the basis of high or low intracellular protein expression and virion release. Potent repression was observed in primary human blood mononuclear cells and a subset of leukemia cell lines. However, the early steps of reverse transcription and integration appear to be unimpaired in nonpermissive cells. FeLV-B was subject to G→A hypermutation with a predominant APOBEC3G signature in partially permissive cells but was not mutated in permissive cells or in nonpermissive cells that block secondary viral spread. Distinct cellular barriers that protect primary human blood cells are likely to be important in protection against zoonotic infection with FeLV.IMPORTANCE Domestic exposure to gammaretroviruses such as feline leukemia viruses (FeLVs) occurs worldwide, but the basis of human resistance to infection remains incompletely understood. The potential threat is evident from the human genome sequence, which reveals many past epidemics of gammaretrovirus infection, and from recent cross-species jumps of gammaretroviruses from rodents to primates and marsupials. This study examined resistance to infection at the cellular level with the most prevalent human cell-tropic FeLV variant, FeLV-B. We found that blood cells are uniquely resistant to infection with FeLV-B due to the activity of cellular enzymes that mutate the viral genome. A second block, which appears to suppress viral gene expression after the viral genome has integrated into the host cell genome, was identified. Since cells derived from other normal human cell types are fully supportive of FeLV replication, innate resistance of blood cells could be critical in protecting against cross-species infection. The human genome displays a rich fossil record of past gammaretrovirus infections, yet no current epidemic is evident, despite environmental exposure to viruses that infect human cells Feline leukemia viruses (FeLVs) rank high on this list, but neither domestic nor workplace exposure has been associated with detectable serological responses. Nonspecific inactivation of gammaretroviruses by serum factors appears insufficient to explain these observations. To investigate further, we explored the susceptibilities of primary and established human cell lines to FeLV-B, the most likely zoonotic variant. Fully permissive infection was common in cancer-derived cell lines but was also a feature of nontransformed keratinocytes and lung fibroblasts. Cells of hematopoietic origin were generally less permissive and formed discrete groups on the basis of high or low intracellular protein expression and virion release. Potent repression was observed in primary human blood mononuclear cells and a subset of leukemia cell lines. However, the early steps of reverse transcription and integration appear to be unimpaired in nonpermissive cells. FeLV-B was subject to G→A hypermutation with a predominant APOBEC3G signature in partially permissive cells but was not mutated in permissive cells or in nonpermissive cells that block secondary viral spread. Distinct cellular barriers that protect primary human blood cells are likely to be important in protection against zoonotic infection with FeLV. Domestic exposure to gammaretroviruses such as feline leukemia viruses (FeLVs) occurs worldwide, but the basis of human resistance to infection remains incompletely understood. The potential threat is evident from the human genome sequence, which reveals many past epidemics of gammaretrovirus infection, and from recent cross-species jumps of gammaretroviruses from rodents to primates and marsupials. This study examined resistance to infection at the cellular level with the most prevalent human cell-tropic FeLV variant, FeLV-B. We found that blood cells are uniquely resistant to infection with FeLV-B due to the activity of cellular enzymes that mutate the viral genome. A second block, which appears to suppress viral gene expression after the viral genome has integrated into the host cell genome, was identified. Since cells derived from other normal human cell types are fully supportive of FeLV replication, innate resistance of blood cells could be critical in protecting against cross-species infection. The human genome displays a rich fossil record of past gammaretrovirus infections, yet no current epidemic is evident, despite environmental exposure to viruses that infect human cells in vitro . Feline leukemia viruses (FeLVs) rank high on this list, but neither domestic nor workplace exposure has been associated with detectable serological responses. Nonspecific inactivation of gammaretroviruses by serum factors appears insufficient to explain these observations. To investigate further, we explored the susceptibilities of primary and established human cell lines to FeLV-B, the most likely zoonotic variant. Fully permissive infection was common in cancer-derived cell lines but was also a feature of nontransformed keratinocytes and lung fibroblasts. Cells of hematopoietic origin were generally less permissive and formed discrete groups on the basis of high or low intracellular protein expression and virion release. Potent repression was observed in primary human blood mononuclear cells and a subset of leukemia cell lines. However, the early steps of reverse transcription and integration appear to be unimpaired in nonpermissive cells. FeLV-B was subject to G→A hypermutation with a predominant APOBEC3G signature in partially permissive cells but was not mutated in permissive cells or in nonpermissive cells that block secondary viral spread. Distinct cellular barriers that protect primary human blood cells are likely to be important in protection against zoonotic infection with FeLV. IMPORTANCE Domestic exposure to gammaretroviruses such as feline leukemia viruses (FeLVs) occurs worldwide, but the basis of human resistance to infection remains incompletely understood. The potential threat is evident from the human genome sequence, which reveals many past epidemics of gammaretrovirus infection, and from recent cross-species jumps of gammaretroviruses from rodents to primates and marsupials. This study examined resistance to infection at the cellular level with the most prevalent human cell-tropic FeLV variant, FeLV-B. We found that blood cells are uniquely resistant to infection with FeLV-B due to the activity of cellular enzymes that mutate the viral genome. A second block, which appears to suppress viral gene expression after the viral genome has integrated into the host cell genome, was identified. Since cells derived from other normal human cell types are fully supportive of FeLV replication, innate resistance of blood cells could be critical in protecting against cross-species infection. |
Author | Ahmad, Shamim Wilson, Sam Watts, Ciorsdaidh Mackay, Nancy Neil, James C. Cameron, Ewan Kilbey, Anna Terry, Anne Levy, Laura S. Naseer, Asif |
Author_xml | – sequence: 1 givenname: Anne surname: Terry fullname: Terry, Anne organization: MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom – sequence: 2 givenname: Anna surname: Kilbey fullname: Kilbey, Anna organization: MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom – sequence: 3 givenname: Asif surname: Naseer fullname: Naseer, Asif organization: MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom – sequence: 4 givenname: Laura S. surname: Levy fullname: Levy, Laura S. organization: Tulane University, New Orleans, Louisiana, USA – sequence: 5 givenname: Shamim surname: Ahmad fullname: Ahmad, Shamim organization: Tulane University, New Orleans, Louisiana, USA – sequence: 6 givenname: Ciorsdaidh surname: Watts fullname: Watts, Ciorsdaidh organization: MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom – sequence: 7 givenname: Nancy surname: Mackay fullname: Mackay, Nancy organization: MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom – sequence: 8 givenname: Ewan surname: Cameron fullname: Cameron, Ewan organization: School of Veterinary Medicine, University of Glasgow, Glasgow, United Kingdom – sequence: 9 givenname: Sam surname: Wilson fullname: Wilson, Sam organization: MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom – sequence: 10 givenname: James C. surname: Neil fullname: Neil, James C. organization: MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28031367$$D View this record in MEDLINE/PubMed |
BookMark | eNpdUctu1DAUtVARnRZ2rJGXLJpy_UjisECiI0oHjVQJQYXYWI7npnVJ7MFOiubv8TClr5Wl6_PQOeeA7PngkZDXDI4Z4-rdl4vFMXDGmoJVz8iMQaOKsmRyj8wAOC9KoX7sk4OUrgGYlJV8Qfa5AsFEVc-IPTExOoyJjoEufId2dMHT0NGzaTCezrHvE2039BR755EucfqFgzP0wsUpvc-U5C6vxkSdzwJfMbk0Gm9xK_czBB_y4SV53pk-4avb95B8P_30bX5WLM8_L-Yfl4UVSo5FVytsjZG8k1ACIlS15SDQmLKpu6ZthEKFuDJS8bpUsIJKyFZUUqoaoFPikBQ73cmvzeaP6Xu9jm4wcaMZ6G1Z-vrG6X9laVZl_Icdfj21A64s-jGae04wTj_-8e5KX4YbXQpoGsmywNtbgRh-T5hGPbhkc2PGY5iSZqqUDCqmRIa-eeh1Z_J_iQzgO4CNIaWInbZuNNsxsrXr7xLkuR8mOHpCehr4EfwvdBqq3w |
CitedBy_id | crossref_primary_10_3390_v10040186 crossref_primary_10_1371_journal_pbio_3000217 crossref_primary_10_1128_MRA_00233_20 crossref_primary_10_1016_j_intimp_2017_08_028 crossref_primary_10_1128_JVI_00020_21 crossref_primary_10_3390_v12030335 |
Cites_doi | 10.1128/JVI.00046-11 10.1038/ncb2879 10.1002/ijc.2910210103 10.1128/jvi.38.2.688-703.1981 10.1073/pnas.1304704110 10.1128/JVI.02411-10 10.1016/S0021-9258(18)47267-5 10.1093/nar/gkh554 10.1371/journal.ppat.1004145 10.1016/j.virol.2010.11.011 10.1128/jvi.71.11.8116-8123.1997 10.1084/jem.182.5.1345 10.1038/ni.3156 10.1099/0022-1317-71-2-343 10.1073/pnas.1217399110 10.1038/2241208a0 10.1038/296156a0 10.1128/jvi.58.3.825-834.1986 10.1016/0042-6822(80)90173-7 10.1016/j.jmb.2004.01.046 10.1371/journal.pone.0004744 10.1292/jvms.70.1383 10.1038/35057062 10.1099/0022-1317-73-11-2839 10.1128/jvi.68.4.2458-2467.1994 10.1128/JVI.02326-12 10.1128/jvi.68.4.2151-2160.1994 10.1007/s00705-011-0925-z 10.1038/nature00939 10.1073/pnas.74.5.1908 10.1126/science.1251343 10.2460/javma.2000.217.1475 10.1128/JVI.73.8.6500-6505.1999 10.1038/srep12230 10.1006/viro.1994.1597 10.1126/science.168.3935.1098 10.1371/journal.pgen.1004167 10.1126/science.287.5459.1828 10.1128/CVI.00705-14 10.1038/sj.onc.1209043 10.7589/2014-04-114 10.1016/0042-6822(71)90266-2 10.1128/jvi.62.3.722-731.1988 10.1038/nature16965 10.1128/jvi.68.12.8296-8303.1994 10.1186/1742-4690-9-112 10.1182/blood.V95.3.1093.003k01_1093_1099 10.1128/JVI.79.10.6478-6486.2005 10.1038/332731a0 10.1371/journal.pone.0154070 10.1128/JVI.02745-15 10.1128/JVI.00839-06 10.1002/ijc.2910210314 10.1128/JVI.80.7.3378-3385.2006 10.1128/jvi.68.12.8001-8007.1994 10.1128/MCB.01293-14 |
ContentType | Journal Article |
Copyright | Copyright © 2017 Terry et al. Copyright © 2017 Terry et al. 2017 Terry et al. |
Copyright_xml | – notice: Copyright © 2017 Terry et al. – notice: Copyright © 2017 Terry et al. 2017 Terry et al. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
DOI | 10.1128/JVI.02119-16 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | FeLV Infection of Human Cells |
EISSN | 1098-5514 |
ExternalDocumentID | 10.1128/jvi.02119-16 PMC5309941 28031367 10_1128_JVI_02119_16 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Medical Research Council grantid: MR/K024752/1 – fundername: NCI NIH HHS grantid: R01 CA083823 – fundername: Medical Research Council grantid: MC_UU_12014/10 – fundername: Medical Research Council grantid: G0801822 – fundername: Cancer Research UK grantid: A11951 – fundername: Cancer Research UK grantid: 11951 – fundername: Bloodwise grantid: 13046 – fundername: HHS | NIH | National Cancer Institute (NCI) grantid: CA083823 – fundername: Cancer Research UK (CRUK) grantid: A11591 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GROUPED_DOAJ GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM AGVNZ CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c384t-f78ebaa42f4050ee067c203eaa597f9b938e8eeda4827580d0634b36448700f83 |
IEDL.DBID | UNPAY |
ISSN | 0022-538X 1098-5514 1070-6321 |
IngestDate | Wed Aug 20 00:09:37 EDT 2025 Tue Sep 30 16:58:53 EDT 2025 Thu Sep 04 16:29:11 EDT 2025 Mon Jul 21 06:02:30 EDT 2025 Thu Apr 24 22:53:11 EDT 2025 Wed Oct 01 01:46:03 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | feline leukemia virus restriction factors zoonosis APOBEC |
Language | English |
License | Copyright © 2017 Terry et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. cc-by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c384t-f78ebaa42f4050ee067c203eaa597f9b938e8eeda4827580d0634b36448700f83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Citation Terry A, Kilbey A, Naseer A, Levy LS, Ahmad S, Watts C, Mackay N, Cameron E, Wilson S, Neil JC. 2017. Barriers to infection of human cells by feline leukemia virus: insights into resistance to zoonosis. J Virol 91:e02119-16. https://doi.org/10.1128/JVI.02119-16. Present address: Asif Naseer, Khyber Medical University, Hayatabad, Peshawar, Khyber Pakhtunkhwa, Pakistan; Shamim Ahmad, Georgia Cancer Center, Augusta University, Augusta, Georgia, USA. |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://jvi.asm.org/content/jvi/91/5/e02119-16.full.pdf |
PMID | 28031367 |
PQID | 1854106183 |
PQPubID | 23479 |
ParticipantIDs | unpaywall_primary_10_1128_jvi_02119_16 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5309941 proquest_miscellaneous_1854106183 pubmed_primary_28031367 crossref_citationtrail_10_1128_JVI_02119_16 crossref_primary_10_1128_JVI_02119_16 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-03-01 |
PublicationDateYYYYMMDD | 2017-03-01 |
PublicationDate_xml | – month: 03 year: 2017 text: 2017-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2017 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_24_2 e_1_3_2_47_2 Rojko JL (e_1_3_2_36_2) 1992; 66 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_58_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_56_2 e_1_3_2_50_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_55_2 e_1_3_2_2_2 |
References_xml | – ident: e_1_3_2_48_2 doi: 10.1128/JVI.00046-11 – ident: e_1_3_2_49_2 doi: 10.1038/ncb2879 – ident: e_1_3_2_13_2 doi: 10.1002/ijc.2910210103 – ident: e_1_3_2_56_2 doi: 10.1128/jvi.38.2.688-703.1981 – ident: e_1_3_2_5_2 doi: 10.1073/pnas.1304704110 – ident: e_1_3_2_52_2 doi: 10.1128/JVI.02411-10 – ident: e_1_3_2_4_2 doi: 10.1016/S0021-9258(18)47267-5 – ident: e_1_3_2_39_2 doi: 10.1093/nar/gkh554 – ident: e_1_3_2_42_2 doi: 10.1371/journal.ppat.1004145 – ident: e_1_3_2_30_2 doi: 10.1016/j.virol.2010.11.011 – ident: e_1_3_2_22_2 doi: 10.1128/jvi.71.11.8116-8123.1997 – ident: e_1_3_2_12_2 doi: 10.1084/jem.182.5.1345 – ident: e_1_3_2_29_2 doi: 10.1038/ni.3156 – ident: e_1_3_2_57_2 doi: 10.1099/0022-1317-71-2-343 – ident: e_1_3_2_31_2 doi: 10.1073/pnas.1217399110 – ident: e_1_3_2_7_2 doi: 10.1038/2241208a0 – ident: e_1_3_2_26_2 doi: 10.1038/296156a0 – ident: e_1_3_2_21_2 doi: 10.1128/jvi.58.3.825-834.1986 – ident: e_1_3_2_41_2 doi: 10.1016/0042-6822(80)90173-7 – ident: e_1_3_2_43_2 doi: 10.1016/j.jmb.2004.01.046 – ident: e_1_3_2_10_2 doi: 10.1371/journal.pone.0004744 – ident: e_1_3_2_34_2 doi: 10.1292/jvms.70.1383 – ident: e_1_3_2_2_2 doi: 10.1038/35057062 – ident: e_1_3_2_23_2 doi: 10.1099/0022-1317-73-11-2839 – volume: 66 start-page: 418 year: 1992 ident: e_1_3_2_36_2 article-title: Lymphocytotoxic strains of feline leukemia-virus induce apoptosis in feline T4-thymic lymphoma-cells publication-title: Lab Invest – ident: e_1_3_2_40_2 doi: 10.1128/jvi.68.4.2458-2467.1994 – ident: e_1_3_2_55_2 doi: 10.1128/JVI.02326-12 – ident: e_1_3_2_28_2 doi: 10.1128/jvi.68.4.2151-2160.1994 – ident: e_1_3_2_33_2 doi: 10.1007/s00705-011-0925-z – ident: e_1_3_2_37_2 doi: 10.1038/nature00939 – ident: e_1_3_2_38_2 doi: 10.1073/pnas.74.5.1908 – ident: e_1_3_2_51_2 doi: 10.1126/science.1251343 – ident: e_1_3_2_11_2 doi: 10.2460/javma.2000.217.1475 – ident: e_1_3_2_25_2 doi: 10.1128/JVI.73.8.6500-6505.1999 – ident: e_1_3_2_50_2 doi: 10.1038/srep12230 – ident: e_1_3_2_44_2 doi: 10.1006/viro.1994.1597 – ident: e_1_3_2_8_2 doi: 10.1126/science.168.3935.1098 – ident: e_1_3_2_15_2 doi: 10.1371/journal.pgen.1004167 – ident: e_1_3_2_27_2 doi: 10.1126/science.287.5459.1828 – ident: e_1_3_2_9_2 doi: 10.1128/CVI.00705-14 – ident: e_1_3_2_16_2 doi: 10.1038/sj.onc.1209043 – ident: e_1_3_2_53_2 doi: 10.7589/2014-04-114 – ident: e_1_3_2_19_2 doi: 10.1016/0042-6822(71)90266-2 – ident: e_1_3_2_32_2 doi: 10.1128/jvi.62.3.722-731.1988 – ident: e_1_3_2_35_2 doi: 10.1038/nature16965 – ident: e_1_3_2_45_2 doi: 10.1128/jvi.68.12.8296-8303.1994 – ident: e_1_3_2_54_2 doi: 10.1186/1742-4690-9-112 – ident: e_1_3_2_24_2 doi: 10.1182/blood.V95.3.1093.003k01_1093_1099 – ident: e_1_3_2_3_2 doi: 10.1128/JVI.79.10.6478-6486.2005 – ident: e_1_3_2_58_2 doi: 10.1038/332731a0 – ident: e_1_3_2_17_2 doi: 10.1371/journal.pone.0154070 – ident: e_1_3_2_6_2 doi: 10.1128/JVI.02745-15 – ident: e_1_3_2_46_2 doi: 10.1128/JVI.00839-06 – ident: e_1_3_2_18_2 doi: 10.1002/ijc.2910210314 – ident: e_1_3_2_20_2 doi: 10.1128/JVI.80.7.3378-3385.2006 – ident: e_1_3_2_14_2 doi: 10.1128/jvi.68.12.8001-8007.1994 – ident: e_1_3_2_47_2 doi: 10.1128/MCB.01293-14 |
SSID | ssj0014464 |
Score | 2.2805552 |
Snippet | The human genome displays a rich fossil record of past gammaretrovirus infections, yet no current epidemic is evident, despite environmental exposure to... |
SourceID | unpaywall pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
SubjectTerms | Animals APOBEC-3G Deaminase - genetics APOBEC-3G Deaminase - metabolism Cats Cell Line, Tumor Disease Susceptibility Gene Expression Genome, Viral HEK293 Cells Humans Leukemia Virus, Feline - physiology Mutation Retroviridae Infections - virology Species Specificity Viral Tropism Virus Integration Virus Replication Virus-Cell Interactions Zoonoses - virology |
Title | Barriers to Infection of Human Cells by Feline Leukemia Virus: Insights into Resistance to Zoonosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28031367 https://www.proquest.com/docview/1854106183 https://pubmed.ncbi.nlm.nih.gov/PMC5309941 https://jvi.asm.org/content/jvi/91/5/e02119-16.full.pdf |
UnpaywallVersion | publishedVersion |
Volume | 91 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1098-5514 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014464 issn: 1098-5514 databaseCode: KQ8 dateStart: 19670201 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1098-5514 dateEnd: 20250403 omitProxy: true ssIdentifier: ssj0014464 issn: 1098-5514 databaseCode: DIK dateStart: 19670101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1098-5514 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014464 issn: 1098-5514 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1098-5514 dateEnd: 20241003 omitProxy: true ssIdentifier: ssj0014464 issn: 1098-5514 databaseCode: RPM dateStart: 19670101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RrRBceEPDozIScEHZjfMOt1KxtBVUCLHV0kvkJBOxbZqsNglo-fXM5CWWFRLi6kwcOx57vrHH3wC8UDKVrpd4ukvLn24jOjrZmUBPMXKNWLJPwRv6H0_do5l9Mnfm3dYF34W5-M43uK6aM3wO1qaVl8smgZw4EzSYj0yX7pj3psfLJN2BXZdPlkawOzv9dPC15wanaTxvow3JObLa21fMnMn4oA9_N_3ma32dm4ZpC21uB03eqPOlWv9QWfabRZrehnnflzYQ5XJcV9E4_vkHzeN_dPYO3OpQqjho1eouXMP8Hlxv81au70P8Vq04010pqkIcd-FcuShS0ZwJiEPMslJEazHl2-4oPmB9iVcLJc4Wq7p8Q6-UvCdQikVOFXzGkkEsaR9Xd14UeUEFD2A2fffl8EjvsjXoseXblZ56PkZK2WZKGNBAJDMYm4aFSpHPkgZRYPnok0VWTDzq-EZC4MiOLPYPPcNIfeshjPIixz0QlgqknSgSUJ6dmk1SdtnQ2qg4SDDQ4HU_VGHcUZlzRo0sbFwa0w9Pzo7D5v-F0tXg5SC9bCk8_iL3vB_1kOYYH5yoHIu6DAnT2Ow6-5YGj1otGGri7F5Me6eBt6EfgwDzd28-yRffGh5vxyJ4bksNXg2atNVAUoehgY__VfAJ3DQZfTShck9hVK1qfEbYqYr2Yef9XO53s-UX1AMUpA |
linkProvider | Unpaywall |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9BJ8Re-GYLDGQk4AWlTeJ87m1MVNsEE0J0KrxETnIR3bKkahJQ-eu5y5coFRLi1bk4dnz2_c4-_w7gpTJT0_UST3dp-dNtREcnOxPoKUauEZvsU_CG_odz92Rmn82debd1wXdhLr_zDa7r5gyfg7Vp5eWySWBOnAkazEemm-6Y96bHyyS9CTsunyyNYGd2_vHoS88NTtN43kYbknMk29tXzJzJ-KAPf7f85mt9nZuGaQttbgdN3q7zpVr_UFn2m0Wa3oV535c2EOVqXFfROP75B83jf3T2HtzpUKo4atXqPtzA_AHcavNWrh9C_FatONNdKapCnHbhXLkoUtGcCYhjzLJSRGsx5dvuKN5jfYXXCyUuFqu6PKRXSt4TKMUipwo-YckglrSPq_taFHlBBY9gNn33-fhE77I16LH07UpPPR8jpWwrJQxoIJIZjC1DolLks6RBFEgffbLIiolHHd9ICBzZkWT_0DOM1JePYZQXOe6DkCow7USRgPLs1GqSspsNrY2KgwQDDd70QxXGHZU5Z9TIwsalsfzw7OI0bP5faLoavBqkly2Fx1_kXvSjHtIc44MTlWNRlyFhGptdZ19qsNdqwVATZ_di2jsNvA39GASYv3vzSb741vB4O5LguW1q8HrQpK0GkjoMDXzyr4JPYddi9NGEyh3AqFrV-IywUxU97-bJL13zE7M |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Barriers+to+Infection+of+Human+Cells+by+Feline+Leukemia+Virus%3A+Insights+into+Resistance+to+Zoonosis&rft.jtitle=Journal+of+virology&rft.au=Terry%2C+Anne&rft.au=Kilbey%2C+Anna&rft.au=Naseer%2C+Asif&rft.au=Levy%2C+Laura+S.&rft.date=2017-03-01&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=91&rft.issue=5&rft_id=info:doi/10.1128%2FJVI.02119-16&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JVI_02119_16 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |